IP Issues in the Therapeutic Antibody Industry

The following section is related to IP issues in the therapeutic Antibody industry. A rough overview over protected enabling techniques and compounds is provided, in order to facilitate the entry into freedom to operate studies. Furthermore, some general information about specific issues is provided, and the stories of some historic lawsuits fought between Antibody companies in the past are being told.